Compare iShares Gold Trust (IAU) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Gold Trust vs Tempus AI — how do they compare? iShares Gold Trust trades at $78.7 (market cap $61.51B), while Tempus AI trades at $70.09 (market cap $12.58B). The key difference: iShares Gold Trust is far larger — about 4.9× Tempus AI's market cap, and Tempus AI is trading nearer its 52-week high, iShares Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Gold Trust for 49 Days and Tempus AI for 22 Days on average.
| IAU | TEM | |
|---|---|---|
Market Cap | $61.51B | $12.58B |
Volume | 3,206,729 | 7,444,569 |
Sector | Commodities - Metals/Agriculture | Broad Market / Factor |
52-Week High | $101.57 | $99.28 |
52-Week Low | $74.21 | $41.55 |
Typical Hold Time | 49 Days | 22 Days |
Enterprise Value | — | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IAU stock trades at $77.06, down 1.67% amid bearish technical signals with 13 of 13 moving averages indicating sell signals. The stock faces pressure from rising Treasury yields and Federal Reserve rate uncertainty, though recent soft inflation data has tempered rate-hike expectations. Support levels cluster around $76-77 while resistance sits at $78.
The outlook remains challenging with technical indicators overwhelmingly bearish and macroeconomic headwinds persisting. However, the RSI_12 reading of 25.07 suggests potential oversold conditions, creating possible tactical opportunities for contrarian investors despite the dominant downward trend.
Tempus AI (TEM) trades at $72.15, up 2.65% today, with a bullish technical signal and strong analyst support. The stock shows recent earnings beats but remains unprofitable, with a net income margin of -17.77% for 2026. Positive developments include FDA clearance for an AI product and expanded data partnerships, fueling investor optimism in the healthtech sector.
Outlook is cautiously optimistic given growth potential in AI-driven diagnostics, but high valuation (P/S 8.61) and persistent losses pose risks. Upside hinges on revenue scaling and path to profitability, with a consensus price target of $72.60 suggesting limited near-term gains from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares Gold Trust
IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.
Read more on IAU →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
